G81971FM
| Organisms | Evidence |
|---|---|
| Homo sapiens (human) |
| Pathway Name | Organism |
|---|---|
| Lewis blood group biosynthesis | Bos taurus |
| Lewis blood group biosynthesis | Sus scrofa |
| Lewis blood group biosynthesis | Caenorhabditis elegans |
| Lewis blood group biosynthesis | Homo sapiens |
| Lewis blood group biosynthesis | Dictyostelium discoideum |
| Lewis blood group biosynthesis | Drosophila melanogaster |
| Lewis blood group biosynthesis | Canis familiaris |
| Lewis blood group biosynthesis | Xenopus tropicalis |
RES 1b:x-dglc-HEX-1:5 2s:n-acetyl 3b:b-dgal-HEX-1:5 4b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d 5s:n-acetyl 6b:a-lgal-HEX-1:5|6:d LIN 1:1d(2+1)2n 2:1o(3+1)3d 3:3o(3+2)4d 4:4d(5+1)5n 5:1o(4+1)6d
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 39368686 | Carbohydrate antigens Lewis a and Lewis b act as tumor markers cooperating with CA19.9 in the management of PDAC patients | Indellicato R | 2025 Jan 15 |
|
| 39591911 | Lactylated histone H3K18 as a potential biomarker for the diagnosis and prediction of the severity of pancreatic cancer | Hou J | 2025 Jan |
|
| 39341838 | Sex-specific association between carbohydrate antigen 19–9 and incident type 2 diabetes | Shin S | 2024 Sep 28 |
|
| 39189647 | A label-free electrochemical biosensor based on a bimetallic organic framework for the detection of carbohydrate antigen 19-9 | Zhao T | 2024 Sep 19 |
|
| 39285510 | Prognosis prediction of <scp>PDAC</scp> via detection of O‐glycan altered extracellular vesicles in perioperative sera | Uemura S | 2024 Sep 16 |
|
| 39287252 | Malignant transformation of ovarian mature cystic teratoma with rupture, elevated serum CA199, CA12, CEA: A case report | Chen L | 2024 Sep 13 |
|
| 39282119 | Serum PCSK9 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer | Xu Y | 2024 Sep 10 |
|
| 39237882 | The preoperative scoring system combining neutrophil/lymphocyte ratio and CA19-9 predicts the long-term prognosis of intrahepatic cholangiocarcinoma patients undergoing curative liver resection | Bai S | 2024 Sep 05 |
|
| 39221763 | Prognostic value of neutrophil to lymphocyte ratio in patients with advanced pancreatic ductal adenocarcinoma treated with systemic chemotherapy | Kitsugi K | 2024 Sep 02 |
|
| 38781696 | High-throughput enrichment of portal venous circulating tumor cells for highly sensitive diagnosis of CA19-9-negative pancreatic cancer patients using inertial microfluidics | Zhu Z | 2024 Sep 01 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025